Growth Metrics

Rxo (RXO) Cash & Current Investments (2021 - 2025)

Rxo's Cash & Current Investments history spans 5 years, with the latest figure at $17.0 million for Q4 2025.

  • For Q4 2025, Cash & Current Investments fell 51.43% year-over-year to $17.0 million; the TTM value through Dec 2025 reached $17.0 million, down 51.43%, while the annual FY2025 figure was $17.0 million, 51.43% down from the prior year.
  • Cash & Current Investments reached $17.0 million in Q4 2025 per RXO's latest filing, down from $25.0 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $187.0 million in Q3 2022 to a low of $5.0 million in Q4 2023.
  • Average Cash & Current Investments over 5 years is $56.5 million, with a median of $29.0 million recorded in 2021.
  • Peak YoY movement for Cash & Current Investments: tumbled 94.9% in 2023, then soared 600.0% in 2024.
  • A 5-year view of Cash & Current Investments shows it stood at $29.0 million in 2021, then soared by 237.93% to $98.0 million in 2022, then crashed by 94.9% to $5.0 million in 2023, then skyrocketed by 600.0% to $35.0 million in 2024, then crashed by 51.43% to $17.0 million in 2025.
  • Per Business Quant, the three most recent readings for RXO's Cash & Current Investments are $17.0 million (Q4 2025), $25.0 million (Q3 2025), and $18.0 million (Q2 2025).